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ABSTRACT  
Endometriosis is an estrogen-dependent gynecological disease that affects 1 out of 10 
women of reproductive age causing severe pelvic pain and infertility. Factors including genetics, 
environment, inflammation, and recently epigenetics have been shown to play roles in the 
pathophysiology of this disease. Histone methylation is an epigenetic modification that 
modulates gene expression by causing changes in the chromatin structure. Trimethylation of 
histone 3 at lysine residue 27 (H3K27me3) is a histone mark related to gene repression.  EZH2 is 
the histone methyltransferase (HMT) responsible of catalyzing H3K27me3. It has been shown 
that the EZH2 is involved in carcinogenesis; however, the specific role of EZH2 in 
endometriosis is unknown. This is important because there are drugs available that block this 
enzyme’s functioning, and could serve as a potential new treatment.  
We have previously shown that endometriotic lesions are characterized by high 
H3K27me3 nuclear immunostaining. Therefore, we hypothesize that EZH2 will be highly 
expressed in lesions compared to endometrium of patients and controls. Using 
immunohistochemistry (IHC) of an endometriosis Tissue Micro Array (TMA), EZH2α and β 
nuclear intensity were assessed using specific antibodies. We observed that pelvic endometriotic 
lesions (peritoneal and fallopian tube) have higher EZH2α intensity scores compared to control 
tissues.  EZH2β nuclear immunostaining analysis is ongoing. We expect to observe a higher 
nuclear intensity score in endometriotic lesions compared to endometriosis free endometria.  
This study is the first to analyze the expression profile of EZH2 isoforms in 
endometriosis. These studies will help better understand the role of EZH2 in this disease.  
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